Novel prognostic alternative splicing events in colorectal Cancer: Impact on immune infiltration and therapy response
-
Published:2024-09
Issue:
Volume:139
Page:112603
-
ISSN:1567-5769
-
Container-title:International Immunopharmacology
-
language:en
-
Short-container-title:International Immunopharmacology
Author:
Xiao YizhiORCID,
Gao Liangqing,
Zhao Xiaojuan,
Zhao Wang,
Mai Lei,
Ma Chengmin,
Han Yanzhi,
Li Xiaofeng
Reference61 articles.
1. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer;Chen;Mol. Cancer,2020
2. miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay - A review;Elrebehy;Int. J. Biol. Macromol.,2022
3. The hsa_circ_0039857/miR-338-3p/RAB32 axis promotes the malignant progression of colorectal cancer;Xu;BMC Gastroenterol.,2022
4. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020;Cao;Chin Med J (Engl),2021
5. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians, 71(3), 209–249. doi: 10.3322/caac.21660.